Nicolas Barthelemy, Director at REPLIGEN CORP (RGEN), sold 26,500 shares at $40.54 ($1.1M) on 2018-05-09, disclosed to the SEC on 2018-05-11.
Seasonal sale ($1.1M) by Director — this insider has traded RGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RGEN | SELL | 2021-11-02 | $578K | — | Filing → |
| MASS | SELL | 2021-06-25 | $754K | — | Filing → |
| TWST | SELL | 2021-02-11 | $1.8M | — | Filing → |